Sinha, J., Zimmerman, K., Balevic, S., Muller, W., Hornik, C., Rathore, M., … Gonzalez, D. (2022). USE OF POPULATION MODELING TO CHARACTERIZE THE PHARMACOKINETICS OF OXCARBAZEPINE AND ITS METABOLITE IN CHILDREN AND ADOLESCENTS WITH OBESITY. In CLINICAL PHARMACOLOGY & THERAPEUTICS (Vol. 111, pp. S48–S48).

Sinha, J., K. Zimmerman, S. Balevic, W. Muller, C. Hornik, M. Rathore, Y. Finkelstein, J. Chen, D. Lipscomb, and D. Gonzalez. “USE OF POPULATION MODELING TO CHARACTERIZE THE PHARMACOKINETICS OF OXCARBAZEPINE AND ITS METABOLITE IN CHILDREN AND ADOLESCENTS WITH OBESITY.” In CLINICAL PHARMACOLOGY & THERAPEUTICS, 111:S48–S48, 2022.

Sinha J, Zimmerman K, Balevic S, Muller W, Hornik C, Rathore M, et al. USE OF POPULATION MODELING TO CHARACTERIZE THE PHARMACOKINETICS OF OXCARBAZEPINE AND ITS METABOLITE IN CHILDREN AND ADOLESCENTS WITH OBESITY. In: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2022. p. S48–S48.

Sinha, J., et al. “USE OF POPULATION MODELING TO CHARACTERIZE THE PHARMACOKINETICS OF OXCARBAZEPINE AND ITS METABOLITE IN CHILDREN AND ADOLESCENTS WITH OBESITY.” CLINICAL PHARMACOLOGY & THERAPEUTICS, vol. 111, 2022, pp. S48–S48.

Sinha J, Zimmerman K, Balevic S, Muller W, Hornik C, Rathore M, Finkelstein Y, Chen J, Lipscomb D, Gonzalez D. USE OF POPULATION MODELING TO CHARACTERIZE THE PHARMACOKINETICS OF OXCARBAZEPINE AND ITS METABOLITE IN CHILDREN AND ADOLESCENTS WITH OBESITY. CLINICAL PHARMACOLOGY & THERAPEUTICS. 2022. p. S48–S48.